Active Fixation Quadripolar Left Ventricular Leads in Cardiac Resynchronization Therapy: Clinical Utility at Mid‐Term Follow‐Up
Journal of Cardiovascular Electrophysiology · 2026-07 · 37 (7) · 1450-1456
DOI: 10.1111/jce.70337 ↗At a glance
Vergleichsstudie in Journal of Cardiovascular Electrophysiology, published online on 2026-05-15. Written by Akinori Wakamiya and 12 co-authors. Institution: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan. Major MEDLINE topics: Cardiac Resynchronization Therapy, Cardiac Resynchronization Therapy Devices, Heart Failure, Ventricular Function, Left. 23 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
This study aimed to evaluate the performance of the Medtronic Attain Stability Quad (ASQ) quadripolar active fixation left ventricular (LV) lead compared with conventional quadripolar passive fixation leads (non‐ASQ) in a mid‐term follow‐up study. Methods and Results A total of 300 consecutive patients (ASQ 159, non‐ASQ 141) who underwent attempted and successful cardiac resynchronization therapy (CRT) device implantation with an LV lead between January 2018 and October 2023 were enrolled. The median follow‐up period was 834 days (766 days in the ASQ group and 938 days in the non‐ASQ group). Complications including elevated pacing capture threshold (PCT), phrenic nerve stimulation (PNS) and LV lead dislodgement were analyzed in the period from implantation to the first outpatient visit after hospital discharge. The incidence of LV lead‐related complications was significantly lower in the ASQ group (19%) than in the non‐ASQ group (32%) ( p = 0.014). Specifically, LV lead dislodgement occurred in the non‐ASQ group only, and elevated PCT was significantly lower in the ASQ group (8% vs. 26%, p < 0.001). Kaplan–Meier analysis confirmed a significantly lower incidence of LV lead‐related complications in the ASQ group (log‐rank p < 0.001). Cox multivariate regression analysis showed a significant reduction in lead‐related complications associated with ASQ (HR: 0.31, 95% CI: 0.19–0.51, p < 0.001).
Conclusion
The ASQ group exhibited fewer LV lead‐related complications requiring reintervention and setting changes than the non‐ASQ group. The ASQ may be accepted as the first choice for CRT device implantation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
ORCID profiles: Akinori Wakamiya, Toshihiro Nakamura, Satoshi Oka, Nobuhiko Ueda, Mitsuru Wada, Yuko Inoue, Koji Miyamoto, Takeshi Aiba, Kengo Kusano
Cite
APA
Wakamiya, A., Ishibashi, K., Oshima, T., Nakamura, T., Oka, S., Ueda, N., Nakajima, K., Kamakura, T., Wada, M., Inoue, Y., Miyamoto, K., Aiba, T., & Kusano, K. (2026). Active Fixation Quadripolar Left Ventricular Leads in Cardiac Resynchronization Therapy: Clinical Utility at Mid‐Term Follow‐Up. Journal of Cardiovascular Electrophysiology, 37(7), 1450-1456. https://doi.org/10.1111/jce.70337
Vancouver
Wakamiya A, Ishibashi K, Oshima T, Nakamura T, Oka S, Ueda N, et al. Active Fixation Quadripolar Left Ventricular Leads in Cardiac Resynchronization Therapy: Clinical Utility at Mid‐Term Follow‐Up. Journal of Cardiovascular Electrophysiology. 2026;37(7):1450-1456. doi:10.1111/jce.70337
BibTeX
@article{Wakamiya2026,
author = {Wakamiya, Akinori and Ishibashi, Kohei and Oshima, Tsukasa and Nakamura, Toshihiro and Oka, Satoshi and Ueda, Nobuhiko and Nakajima, Kenzaburo and Kamakura, Tsukasa and Wada, Mitsuru and Inoue, Yuko and Miyamoto, Koji and Aiba, Takeshi and Kusano, Kengo},
title = {Active Fixation Quadripolar Left Ventricular Leads in Cardiac Resynchronization Therapy: Clinical Utility at Mid‐Term Follow‐Up},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
volume = {37},
number = {7},
pages = {1450--1456},
doi = {10.1111/jce.70337}
}
EUVIMED